F-group (family)
2003.1.1.2 Ldh_1_N
Ligands and drugs
2,176
Member domains
925
with ligand contacts (≤ 4 Å)
42.5% of members
830
with DrugDomain annotations
38.1% of members
651
with a DrugBank compound
29.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.1.2 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB14128 | NAD | Nadide | 251 |
| DB00157 | NAI | NADH | 171 |
| DB03940 | OXM | Oxamic Acid | 85 |
| DB00119 | PYR | Pyruvic acid | 24 |
| DB02637 | OAA | Oxaloacetate Ion | 14 |
| DB03066 | LAC | D-Lactic acid | 13 |
| DB04551 | FBP | beta-D-fructofuranose 1,6-bisphosphate | 12 |
| DB02401 | OXQ | 4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid | 11 |
| DB03363 | A3D | 3-Acetylpyridine Adenine Dinucleotide | 10 |
| DB16833 | ADP | Adenosine disphosphate | 9 |
| DB14475 | 2OP | L-Lactic acid | 8 |
| DB01677 | FUM | Fumaric acid | 6 |
| DB02338 | NDP | NADPH | 6 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 5 |
| DB11091 | PEO | Hydrogen peroxide | 5 |
| DB03709 | BCN | Bicine | 4 |
| DB00117 | HIS | Histidine | 3 |
| DB02175 | MLA | Malonic acid | 3 |
| DB11638 | — | — | 3 |
| DB00131 | AMP | Adenosine phosphate | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 257 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 185 |
| OXM | OXAMIC ACID | 110 |
| CL | CHLORIDE ION | 60 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 34 |
| Kmetal | POTASSIUM ION | 28 |
| NAmetal | SODIUM ION | 27 |
| PYR | PYRUVIC ACID | 24 |
| AGmetal | SILVER ION | 20 |
| APR | ADENOSINE-5-DIPHOSPHORIBOSE | 17 |
| OAA | OXALOACETATE ION | 14 |
| LAC | LACTIC ACID | 13 |
| 6V0 | [[(2~{R},3~{S},4~{R},5~{R})-5-(5-aminocarbonyl-2~{H}-pyridin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate | 12 |
| 88S | N-(2-METHYL-1,3-BENZOTHIAZOL-6-YL)-3-UREIDO-PROPANAMIDE | 12 |
| LMR | (2S)-2-hydroxybutanedioic acid | 11 |
| OXQ | 4-HYDROXY-1,2,5-OXADIAZOLE-3-CARBOXYLIC ACID | 11 |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | 10 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 9 |
| 1E4 | 1-O-[3-(5-carboxypyridin-2-yl)-5-fluorophenyl]-6-O-[4-({[(5-carboxypyridin-2-yl)sulfanyl]acetyl}amino)-2-chloro-5-methoxyphenyl]-D-mannitol | 8 |
| 1E5 | 6-[3-(carboxymethoxy)-5-fluorophenyl]pyridine-3-carboxylic acid | 8 |